Javascript must be enabled to continue!
PROLONGED OZURDEX-MACULAR CONTACT FOLLOWING VITRECTOMY FOR MACULAR HOLE
View through CrossRef
Purpose:
To evaluate the outcome of prolonged ozurdex-macular contact following vitrectomy for macular hole.
Methods and Patients:
A 63-year-old woman with subtle vitreomacular traction and macula edema in the left eye underwent femto laser-assisted cataract surgery with lens implant and ozurdex injection. Postoperatively, patient developed macular hole for which she underwent vitrectomy.
Results:
The steroid implant that remained in contact with the fovea for 16 weeks disappeared on its own without causing any retinal toxicity, and the best-corrected visual acuity improved to 6/9.
Conclusion:
Vitreomacular traction with edema may worsen after cataract surgery and ozurdex injection. Ophthalmologists should keep in mind this rare possible complication and make patients aware of the same.
Ovid Technologies (Wolters Kluwer Health)
Title: PROLONGED OZURDEX-MACULAR CONTACT FOLLOWING VITRECTOMY FOR MACULAR HOLE
Description:
Purpose:
To evaluate the outcome of prolonged ozurdex-macular contact following vitrectomy for macular hole.
Methods and Patients:
A 63-year-old woman with subtle vitreomacular traction and macula edema in the left eye underwent femto laser-assisted cataract surgery with lens implant and ozurdex injection.
Postoperatively, patient developed macular hole for which she underwent vitrectomy.
Results:
The steroid implant that remained in contact with the fovea for 16 weeks disappeared on its own without causing any retinal toxicity, and the best-corrected visual acuity improved to 6/9.
Conclusion:
Vitreomacular traction with edema may worsen after cataract surgery and ozurdex injection.
Ophthalmologists should keep in mind this rare possible complication and make patients aware of the same.
Related Results
Ozurdex in the lens is a rare complication of intravitreal injection (clinical case)
Ozurdex in the lens is a rare complication of intravitreal injection (clinical case)
A clinical case of unintentional implantation of the Ozurdex dexamethasone implant (Allergan, Inc., Irvine, CA, USA) into the lens is presented. The patient was treated for a long ...
Review of the Drug-infused Eye Implant—Ozurdex® (Dexamethasone Intravitreal Implant)
Review of the Drug-infused Eye Implant—Ozurdex® (Dexamethasone Intravitreal Implant)
Ozurdex® (dexamethasone intravitreal implant, Allergan, Inc., Irvine, CA) is an intravitreal implant designed to provide sustained, controlled release of dexamethasone to treat inf...
Prognostic Role of Optical Coherence Tomography in Outcome of Idiopathic full thickness Macular Hole Surgery
Prognostic Role of Optical Coherence Tomography in Outcome of Idiopathic full thickness Macular Hole Surgery
Abstract
Purpose: To assess the prognostic value of Optical Coherence Tomography indices preoperatively in outcome of idiopathic full thickness macular hole surgery.
Ma...
Multifocal Electroretinogram Changes after Vitrectomy in Patients with Diabetic Macular Edema
Multifocal Electroretinogram Changes after Vitrectomy in Patients with Diabetic Macular Edema
Abstract
Purpose: was to assess the results of vitrectomy with and without internal limiting membrane (ILM) peeling on retinal function and anatomy in patients with diabeti...
MODIFICATION OF ADJUSTABLE MACULAR BUCKLING WITH 29-G CHANDELIER LIGHT FOR OPTIMAL POSITIONING IN HIGHLY MYOPIC EYES WITH MACULAR HOLE
MODIFICATION OF ADJUSTABLE MACULAR BUCKLING WITH 29-G CHANDELIER LIGHT FOR OPTIMAL POSITIONING IN HIGHLY MYOPIC EYES WITH MACULAR HOLE
Purpose:
To evaluate the efficacy of the modification of Adjustable Macular Buckling device in the treatment of myopic macular hole retinal detachment with posterior st...
Prevalence of idiopathic macular hole in adult rural and urban south Indian population
Prevalence of idiopathic macular hole in adult rural and urban south Indian population
AbstractBackground: This study was undertaken to evaluate the prevalence of idiopathic macular hole in a defined community in Southern India.Methods: In all, 7774 of the 9546 enu...
623 QIP: Introducing a Dedicated Ozurdex Clinic
623 QIP: Introducing a Dedicated Ozurdex Clinic
Abstract
Aim
To assess the feasibility and benefits of establishing a dedicated clinic for Ozurdex™ (dexamethasone intravitreal ...
Ozurdex implant in retinal vein occlusions. 3‐months clinical outcomes in the first 17 patients
Ozurdex implant in retinal vein occlusions. 3‐months clinical outcomes in the first 17 patients
AbstractPurpose To present the our initial clinical outcomes of dexamethasone 0.7mg intravitreal implant (Ozurdex®) in the first three months after the injection.Methods Seventeen ...

